266 related articles for article (PubMed ID: 10657666)
1. Experimental autoimmune encephalomyelitis on the SJL mouse: effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system.
Rajan AJ; Asensio VC; Campbell IL; Brosnan CF
J Immunol; 2000 Feb; 164(4):2120-30. PubMed ID: 10657666
[TBL] [Abstract][Full Text] [Related]
2. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
Matejuk A; Adlard K; Zamora A; Silverman M; Vandenbark AA; Offner H
J Neurosci Res; 2001 Sep; 65(6):529-42. PubMed ID: 11550221
[TBL] [Abstract][Full Text] [Related]
3. Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein.
Matejuk A; Vandenbark AA; Burrows GG; Bebo BF; Offner H
J Immunol; 2000 Apr; 164(7):3924-31. PubMed ID: 10725756
[TBL] [Abstract][Full Text] [Related]
4. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE.
Adamus G; Manczak M; Machnicki M
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2894-903. PubMed ID: 11687534
[TBL] [Abstract][Full Text] [Related]
5. Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression.
Fischer FR; Santambrogio L; Luo Y; Berman MA; Hancock WW; Dorf ME
J Neuroimmunol; 2000 Oct; 110(1-2):195-208. PubMed ID: 11024550
[TBL] [Abstract][Full Text] [Related]
6. A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system.
Kohler RE; Caon AC; Willenborg DO; Clark-Lewis I; McColl SR
J Immunol; 2003 Jun; 170(12):6298-306. PubMed ID: 12794163
[TBL] [Abstract][Full Text] [Related]
7. Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis.
Fife BT; Paniagua MC; Lukacs NW; Kunkel SL; Karpus WJ
J Neurosci Res; 2001 Nov; 66(4):705-14. PubMed ID: 11746391
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
Tran EH; Prince EN; Owens T
J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
[TBL] [Abstract][Full Text] [Related]
9. A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse.
Rajan AJ; Gao YL; Raine CS; Brosnan CF
J Immunol; 1996 Jul; 157(2):941-9. PubMed ID: 8752949
[TBL] [Abstract][Full Text] [Related]
10. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
11. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
[TBL] [Abstract][Full Text] [Related]
12. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis.
Fife BT; Kennedy KJ; Paniagua MC; Lukacs NW; Kunkel SL; Luster AD; Karpus WJ
J Immunol; 2001 Jun; 166(12):7617-24. PubMed ID: 11390519
[TBL] [Abstract][Full Text] [Related]
13. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
Huang DR; Wang J; Kivisakk P; Rollins BJ; Ransohoff RM
J Exp Med; 2001 Mar; 193(6):713-26. PubMed ID: 11257138
[TBL] [Abstract][Full Text] [Related]
14. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
Karpus WJ; Lukacs NW; McRae BL; Strieter RM; Kunkel SL; Miller SD
J Immunol; 1995 Nov; 155(10):5003-10. PubMed ID: 7594507
[TBL] [Abstract][Full Text] [Related]
15. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor.
Tran EH; Kuziel WA; Owens T
Eur J Immunol; 2000 May; 30(5):1410-5. PubMed ID: 10820388
[TBL] [Abstract][Full Text] [Related]
16. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis.
Ponomarev ED; Novikova M; Yassai M; Szczepanik M; Gorski J; Dittel BN
J Immunol; 2004 Aug; 173(3):1587-95. PubMed ID: 15265886
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats.
Jee Y; Yoon WK; Okura Y; Tanuma N; Matsumoto Y
J Neuroimmunol; 2002 Jul; 128(1-2):49-57. PubMed ID: 12098510
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.
Matsui M; Weaver J; Proudfoot AE; Wujek JR; Wei T; Richer E; Trapp BD; Rao A; Ransohoff RM
J Neuroimmunol; 2002 Jul; 128(1-2):16-22. PubMed ID: 12098506
[TBL] [Abstract][Full Text] [Related]
19. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.
Sebastiani S; Allavena P; Albanesi C; Nasorri F; Bianchi G; Traidl C; Sozzani S; Girolomoni G; Cavani A
J Immunol; 2001 Jan; 166(2):996-1002. PubMed ID: 11145678
[TBL] [Abstract][Full Text] [Related]
20. Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis.
Glabinski AR; Tuohy VK; Ransohoff RM
Neuroimmunomodulation; 1998; 5(3-4):166-71. PubMed ID: 9730682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
